Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study
Por:
Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda, C, Boned, S, Doncel-Moriano, A, Urra, X, Camps-Renom, P, de la Ossa, NP, Terceño, M, Yugueros, B, Ustrell, X, Purroy, F, Rodríguez-Campello, A, Molina, C, Krupinski, J, Aguirre, GF, Baraldes, M, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, Abilleira, S, Cardona, P and Gómez-Choco, M
Publicada:
1 mar 2026
Ahead of Print:
1 feb 2026
Resumen:
Background and Purpose: The management of patients with anterior circulation large vessel occlusion (LVO) presenting with mild neurological symptoms remains a matter of debate. Early neurological deterioration (END) may influence the decision to perform endovascular treatment (EVT); however, evidence regarding its impact on clinical outcomes is limited. Methods: We conducted a retrospective analysis of prospectively collected data from the Catalan Stroke Registry (2016-2021). Patients with anterior circulation LVO, baseline NIHSS <= 5, baseline mRS score 0-1, and treatment with EVT were included. END was defined as an increase of >= 4 NIHSS points from hospital admission to EVT initiation. Proximal occlusion was defined as occlusion of the extracranial or terminal internal carotid artery or the M1 segment of the middle cerebral artery. The primary outcome was excellent functional outcome at 90 days (mRS 0-1). Good functional outcome (mRS 0-2) was considered a secondary outcome. Mortality and symptomatic intracranial hemorrhage were assessed as safety outcomes. Results: Among 244 patients, 58 (23.8%) experienced END before EVT. At 90 days, 131 patients (53.7%) achieved mRS 0-1 and 162 (66.4%) achieved mRS 0-2. Fourteen patients (5.7%) died during follow-up, and 8 (3.3%) experienced symptomatic intracranial hemorrhage. In multivariable analysis, successful recanalization was independently associated with the primary outcome (OR 4.54, 95% CI 1.73-13.83), whereas END before EVT (OR 1.24, 95% CI 0.40-3.98), proximal occlusion (OR 1.37, 95% CI 0.69-2.71), and their interaction (OR 0.42, 95% CI 0.10-1.67) were not independently associated with excellent functional outcome. Conclusions: In this cohort of patients with mild ischemic stroke treated with EVT, END before EVT was not independently associated with functional outcomes, whereas successful recanalization remained the main determinant of excellent recovery. Pending evidence from randomized clinical trials, these findings suggest that close clinical monitoring with rescue EVT may be an appropriate approach in selected patients.
Filiaciones:
Font, MA:
Consorci Hosp Vic, Neurol Dept, Vic, Spain
Univ Cent Catalunya, Univ Vic, Fac Med, Vic, Barcelona, Spain
UVIC, UCC, Escola Doctorat, Vic, Spain
García-Sánchez, SM:
Complex Hosp Univ Moises Broggi, Neurol Dept, Sant Joan Despi, Spain
Mengual, JJ:
Complex Hosp Univ Moises Broggi, Neurol Dept, Sant Joan Despi, Spain
Avellaneda, C:
Complex Hosp Univ Moises Broggi, Neurol Dept, Sant Joan Despi, Spain
Boned, S:
Complex Hosp Univ Moises Broggi, Neurol Dept, Sant Joan Despi, Spain
Doncel-Moriano, A:
Hosp Clin Barcelona, Neurol Dept, Funct Unit Cerebrovascu Disorders, Barcelona, Spain
Urra, X:
Hosp Clin Barcelona, Neurol Dept, Funct Unit Cerebrovascu Disorders, Barcelona, Spain
Camps-Renom, P:
Hosp Santa Creu & Sant Pau, Neurol Dept, Barcelona, Spain
:
Hosp Santa Creu & Sant Pau, Neurol Dept, Barcelona, Spain
Terceño, M:
Hosp Univ Dr Josep Trueta, Neurol Dept, Girona, Spain
:
Hosp Badalona Germans Trias & Pujol, Neurol Dept, Cerebrovasc Disorders Unit, Badalona, Spain
Ustrell, X:
Hosp Univ Joan XXIII, Neurol Dept, Tarragona, Spain
Purroy, F:
UdL, Hosp Univ Arnau Vilanova, Neurol Dept, Grup Neurociencies Clin IRBLleida, Lleida, Spain
Rodríguez-Campello, A:
Hosp Mar, Neurol Dept, Barcelona, Spain
Molina, C:
Vall dHebron Inst Recerca, Neurol Dept, Barcelona, Spain
Krupinski, J:
F Ass Mutua Terrassa, Neurol Dept, Terrassa, Spain
Manchester Met Univ, Dept Life Sci, Manchester, England
Aguirre, GF:
Hosp Parc Tauli, Neurol Dept, Sabadell, Spain
Baraldes, M:
Hosp St Joan Deu, Neurol Dept, Fdn Althaia, Manresa, Spain
Jiménez-Fàbrega, X:
Serv Emergencies Med, Lhospitalet De Llobregat, Spain
Salvat-Plana, M:
Malaltia Vasc Cerebral, Dept Salut, Barcelona, Spain
Elosua, R:
Univ Cent Catalunya, Univ Vic, Fac Med, Vic, Barcelona, Spain
Hosp Mar Res Inst IMIM, Barcelona, Spain
Inst Salud Carlos III, CIBER Enfermedades Cardiovasc, Barcelona, Spain
Abilleira, S:
Malaltia Vasc Cerebral, Dept Salut, Barcelona, Spain
Cardona, P:
Malaltia Vasc Cerebral, Dept Salut, Barcelona, Spain
Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
Gómez-Choco, M:
Complex Hosp Univ Moises Broggi, Neurol Dept, Sant Joan Despi, Spain
Inst Invest Biomed Bellvitge IDIBELL, Lhospitalet De Llobregat, Spain
gold
|